Vemurafenib

Category: Cancer

Vemurafenib (INN, marketed as Zelboraf) is an inhibitor of the B-Raf enzyme developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma.[1] The name "vemurafenib" comes from V600E mutated BRAF inhibition. Contents 1 Approvals 2 Mechanism of action 2.1 Resistance 3 Clinical trials 3.1 Side effects 4 References 5 Further reading 6 External links Approvals Vemurafenib received FDA approval for the treatment of late-stage... [wikipedia]

3 Discussions

Related Brands

Drugs with the same active ingredients

Popular Topics

Vemurafenib stopped working!

I have a friend who has been on vemurafenib for the past 4 months, doctors have now found new cancer growths and have th...

1 REPLY
Vemurafenib

My sister has 2 melanoma brain metastatic tumors. The first was treated with radiotherapy but the second is in an inoper...